Looking to publish in Science Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowScience Translational Medicine is a weekly online journal publishing research at the intersection of science, engineering, and medicine. Its goal is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers across established and emerging disciplines relevant to medicine.
Looking to publish in Science Translational Medicine? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Science Translational Medicine is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:
Research Articles
Reviews
Research Resources
Recent Publications
HIV-1 infection converts CD4 + T cells to HLA class II–restricted CD8 + T cells
Jinfeng Cai, Wei Dong, Peipei Wang, Jiacong Zhao, Xinyu Liang, Zhuoyue Meng, Wei Wang, Jiasheng Zhou, Haixiang Peng, Huixin Wu, Shubin Chen, Jiazhen Chen, Hongbo Gao, Qiankun Wang, Haitao Zhang, Ting Huang, Lilin Wang, Zhanlian Huang, Liang Shan, Zhonghui Tang, Kai Deng
Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction
Caiwei Guo, Kuchuan Chen, Sarat Vatsavayai, Tetsuya Akiyama, Chang Liu, Yi Zeng, Odilia Sianto, Edith Yang, Juliane Bombosch, Rasheen Powell, Shannon Zhen, Shila Mekhoubad, Ryan D. Morrie, Georgiana Miller, Dragana Ilic, Moritz Boll, Euan Parnell, Peter Penzes, Noa Lipstein, Eric M. Green, Leonard Petrucelli, William W. Seeley, Aaron D. Gitler
Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and TLR5 deficiency is associated with human IPF
Yosuke Sakamachi, Emma Wiley, Carol S. Trempus, Harrison Jacobs, Alma Solis, Collin G. Johnson, Xianglin Meng, Salik Hussain, Amelia Roselli, Jay H. Lipinski, David N. O’Dwyer, Thomas A. Randall, Jason Malphurs, Brian Papas, Benjamin G. Wu, Yonghua Li, Matthias C. Kugler, Sanya Mehta, Erica Scappini, Seddon Y. Thomas, Jian-Liang Li, Lecong Zhou, Peer W. Karmaus, Fred B. Lih, Michael B. Fessler, John A. McGrath, Kevin Gibson, Daniel J. Kass, Anatoli Gleiberman, Ekaterina Andrianova, Avram Walts, Rachele Invernizzi, Philip L. Molyneaux, Ivana V. Yang, Yingze Zhang, Naftali Kaminski, Leopoldo N. Segal, David A. Schwartz, Andrei V. Gudkov, Stavros Garantziotis
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sites
Daniel L. Moss, Jiaxuan Cheng, Peter W. Krug, Alden C. Paine, Brian E. Fisher, Amy R. Henry, Jesmine Roberts-Torres, Timothy S. Johnston, Sarah C. Smith, Sergei Pletnev, Haotian Lei, Nicholas C. Morano, Theodore C. Pierson, Lawrence Shapiro, Tongqing Zhou, Peter D. Kwong, Daniel C. Douek, Masaru Kanekiyo, Tracy J. Ruckwardt
Frequently asked questions
How long does it take to publish?
Original research papers are freely accessible with registration 12 months after publication.
Reformat to Science Translational Medicine using Livewrite PremiumIs a cover letter required?
Authors who use AI-assisted technologies as aids in writing or presentation should disclose this in the cover letter and in the methods section or acknowledgments, depending on use case.
Reformat to Science Translational Medicine using Livewrite PremiumWhat are the publication costs?
Individual access is available through an add-on subscription or membership upgrade.
Reformat to Science Translational Medicine using Livewrite Premium